Diagnostic Kits/Data, narratives and tools produced by the Kits' sector: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 2: | Line 2: | ||
=Genetic Diagnostic Case Studies= | =Genetic Diagnostic Case Studies= | ||
The following are summaries of IP and commercialization information of commercially available diagnostic kits. A subset of this list will be developed into more extensive case studies. The old spreadsheet form of this information is available [[Data, narratives and tools produced by the Kits' sector/GeneDxChart|here]]. | |||
== Breast and Ovarian Cancer == | == Breast and Ovarian Cancer == | ||
| Line 13: | Line 14: | ||
*: BRACAnalysis | *: BRACAnalysis | ||
*: $3120 | *: $3120 | ||
= References = | = References = | ||
Revision as of 18:04, 23 November 2009
Types of inputs for kits
Genetic Diagnostic Case Studies
The following are summaries of IP and commercialization information of commercially available diagnostic kits. A subset of this list will be developed into more extensive case studies. The old spreadsheet form of this information is available here.
Breast and Ovarian Cancer
BRCA1
- Patent Holders
- Myriad Genetics (exclusive licensee)
- key patents
- 5753441, 6051379,
- products
- BRACAnalysis
- $3120